{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:47:27Z","timestamp":1792000047669,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perioperative immunochemotherapy is recommended for resectable non-small cell lung cancer (NSCLC) with \u2265\u20094-cm tumors or clinical nodal involvement (cN(+)). Therefore, accurate preoperative nodal assessment is crucial in &lt;\u20094-cm tumors, where false-positive cN staging should be carefully considered. This multicenter study aimed to develop and validate a prediction model to identify patients at high risk of cN(+)pN(\u2212) disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The development cohort included 251 patients with tumors\u2009&lt;\u20094\u00a0cm who were diagnosed as cN(+) using positron emission tomography and underwent curative anatomical resection with mediastinal lymph node dissection between 2010 and 2020. The model predicting cN(+)pN(\u2212) was developed and subsequently validated in a temporally independent validation cohort of 108 patients treated during periods different from those of the development cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the development cohort, 72 patients (28.7%) were cN(+)pN(\u2212). In multivariable analysis, age\u2009\u2265\u200967 years (odds ratio [OR] 2.85,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), right-sided tumor (OR 2.50,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006), carcinoembryonic antigen\u2009\u2264\u200912 ng\/mL (OR 3.11,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048), cN1 (OR 2.37,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025), and tumor maximum standardized uptake value\u2009\u2264\u20096.5 (OR 2.03,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023) were independent predictors for cN(+)pN(\u2212). The prediction model showed a C-index of 0.74 (95% confidence interval [CI] 0.67\u20130.81), specificity of 94.4%, and positive predictive value (PPV) of 66.7% in the development cohort. In the validation cohort, the C-index was 0.77 (95% CI 0.67\u20130.86) with good calibration (slope, 1.002; intercept, 0.001), specificity (96.3%), and PPV (70.0%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with &lt;\u20094-cm cN(+) NSCLC, a simple model based on five readily available preoperative factors can identify individuals at high risk of false-positive nodal staging with high specificity. This model may help identify patients in whom upfront surgery for definitive pathological nodal evaluation may be preferable rather than immediate neoadjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16580-4","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:45:47Z","timestamp":1784281547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multicenter prediction model for false-positive clinical nodal disease in &lt;\u20094-cm NSCLC: clinical implications for upfront surgery versus neoadjuvant therapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Tetsuya","family":"Isaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"16580_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"16580_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","volume":"12","author":"P Goldstraw","year":"2017","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2017;12:1109\u201321.","journal-title":"J Thorac Oncol"},{"key":"16580_CR3","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386:1973\u201385.","journal-title":"N Engl J Med"},{"key":"16580_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","volume":"389","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med. 2023;389:491\u2013503.","journal-title":"N Engl J Med"},{"key":"16580_CR5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","volume":"389","author":"JV Heymach","year":"2023","unstructured":"Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, et al. Perioperative durvalumab for resectable non-small-cell lung cancer. N Engl J Med. 2023;389:1672\u201384.","journal-title":"N Engl J Med"},{"key":"16580_CR6","volume-title":"NCCN clinical practice guidelines in oncology: non-small cell lung cancer, version 3.2025","author":"National Comprehensive Cancer Network","year":"2025","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer, version 3.2025. Plymouth, PA: NCCN; 2025."},{"key":"16580_CR7","volume-title":"Guideline for diagnosis and treatment of lung cancer\/malignant pleural mesothelioma\/thymic tumors","author":"Japanese Lung Cancer Society","year":"2025","unstructured":"Japanese Lung Cancer Society. Guideline for diagnosis and treatment of lung cancer\/malignant pleural mesothelioma\/thymic tumors. Japan: Japanese Lung Cancer Society; 2025."},{"key":"16580_CR8","unstructured":"National Institute for Health and Care Excellence. Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer (TA876). 2023. https:\/\/www.nice.org.uk\/guidance\/ta876."},{"key":"16580_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","volume":"45","author":"P De Leyn","year":"2014","unstructured":"De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45:787\u201398.","journal-title":"Eur J Cardiothorac Surg"},{"key":"16580_CR10","doi-asserted-by":"publisher","first-page":"eS211","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, Margolis AT, Gould R, Tanoue MK, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:eS211\u201350.","journal-title":"Chest"},{"key":"16580_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.lungcan.2020.10.022","volume":"150","author":"F Beyaz","year":"2020","unstructured":"Beyaz F, Verhoeven RLJ, Schuurbiers OCJ, Verhagen AFTM, van der Heijden EHFM. Occult lymph node metastases in clinical N0\/N1 NSCLC: a single center in-depth analysis. Lung Cancer. 2020;150:186\u201394.","journal-title":"Lung Cancer"},{"key":"16580_CR12","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.21037\/jtd.2018.01.51","volume":"10","author":"R Zhang","year":"2018","unstructured":"Zhang R, Ma Y, Xu G, Gao X, Luo G, Lin Q, et al. Endobronchial ultrasound-guided transbronchial needle aspiration and cervical mediastinoscopy for mediastinal staging of non-small cell lung cancer: a retrospective comparison study. J Thorac Dis. 2018;10:1951\u20139.","journal-title":"J Thorac Dis"},{"key":"16580_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1183\/09059180.00001113","volume":"22","author":"C Dooms","year":"2013","unstructured":"Dooms C, Muylle I, Yserbyt J, Ninane V. Endobronchial ultrasound in the management of nonsmall cell lung cancer. Eur Respir Rev. 2013;22:169\u201377.","journal-title":"Eur Respir Rev"},{"key":"16580_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.chest.2018.10.020","volume":"155","author":"N Navani","year":"2019","unstructured":"Navani N, Fisher DJ, Tierney JF, Stephens RJ, Burdett S, Burdett S, et al. The accuracy of clinical staging of stage I\u2013IIIa non-small cell lung cancer: an analysis based on individual participant data. Chest. 2019;155:502\u20139.","journal-title":"Chest"},{"key":"16580_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.athoracsur.2006.05.023","volume":"82","author":"A Lemaire","year":"2006","unstructured":"Lemaire A, Nikolic I, Petersen T, Haney J, Meyers D, Burdett S, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006;82:1185\u20139.","journal-title":"Ann Thorac Surg"},{"key":"16580_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.athoracsur.2016.06.071","volume":"102","author":"DJ Heineman","year":"2016","unstructured":"Heineman DJ, ten Berge MG, Daniels JM, Versteegh MI, Marang-van de Mheen PJ, Wouters MW, et al. The quality of staging non-small cell lung cancer in the Netherlands: data from the Dutch Lung Surgery Audit. Ann Thorac Surg. 2016;102:1622\u20139.","journal-title":"Ann Thorac Surg"},{"key":"16580_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lungcan.2022.07.014","volume":"171","author":"S Solberg","year":"2022","unstructured":"Solberg S, Nilssen Y, Terje Brustugun O, Magnus Haram P, Helland \u00c5, M\u00f8ller B, et al. Concordance between clinical and pathology TNM-staging in lung cancer. Lung Cancer. 2022;171:65\u20139.","journal-title":"Lung Cancer"},{"key":"16580_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejcts.2009.07.026","volume":"37","author":"I Macia","year":"2010","unstructured":"Macia I, Moya J, Escobar I, Ramos R, Masuet C, Gamez C, et al. Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging. Eur J Cardiothorac Surg. 2010;37:540\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"key":"16580_CR19","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","volume":"390","author":"T Cascone","year":"2024","unstructured":"Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, et al. Perioperative nivolumab in resectable lung cancer. N Engl J Med. 2024;390:1756\u201369.","journal-title":"N Engl J Med"},{"key":"16580_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"16580_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.athoracsur.2004.06.041","volume":"79","author":"\u00d6 Birim","year":"2005","unstructured":"Birim \u00d6, Kappetein AP, Stijnen T, Bogers AJJC. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg. 2005;79:375\u201382.","journal-title":"Ann Thorac Surg"},{"key":"16580_CR22","first-page":"11","volume":"2016","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqu\u00e9 i Figuls M. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;2016:11.","journal-title":"Cochrane Database Syst Rev"},{"key":"16580_CR23","first-page":"e922675","volume":"26","author":"X Zhai","year":"2020","unstructured":"Zhai X, Guo Y, Qian X. Combination of 18F-FDG PET\/CT and tumor markers to diagnose lymph node metastasis in NSCLC. Med Sci Monit. 2020;26:e922675.","journal-title":"Med Sci Monit"},{"key":"16580_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","volume":"139","author":"MK Gould","year":"2003","unstructured":"Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003;139:879\u201392.","journal-title":"Ann Intern Med"},{"key":"16580_CR25","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2967\/jnumed.107.044362","volume":"18","author":"D Hellwig","year":"2007","unstructured":"Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers H-J, et al. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med. 2007;18:1761\u20136.","journal-title":"J Nucl Med"},{"key":"16580_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.athoracsur.2005.12.047","volume":"82","author":"AS Bryant","year":"2006","unstructured":"Bryant AS, Cerfolio RJ, Klemm KM, Ojha B. Maximum SUV of mediastinal lymph nodes on integrated FDG-PET\/CT predicts pathology in NSCLC. Ann Thorac Surg. 2006;82:417\u201322.","journal-title":"Ann Thorac Surg"},{"key":"16580_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","volume":"32","author":"J Remon","year":"2021","unstructured":"Remon J, Soria JC, Peters S. Early and locally advanced NSCLC: update of the ESMO clinical practice guidelines. Ann Oncol. 2021;32:1637\u201342.","journal-title":"Ann Oncol"},{"key":"16580_CR28","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/1759-7714.14587","volume":"13","author":"S Wi","year":"2022","unstructured":"Wi S, Kim B, Shin SH, Jhun BW, Yoo H, Jeong B, et al. Clinical utility of EBUS-TBNA of hilar, interlobar, and lobar lymph nodes in patients with primary lung cancer. Thorac Cancer. 2022;13:2507\u201314.","journal-title":"Thorac Cancer"},{"key":"16580_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/diagnostics13030403","volume":"13","author":"F Damirov","year":"2023","unstructured":"Damirov F, B\u00fcsing K, Yavuz G, Korkmaz M, Hekimoglu M. Accuracy of 18F-FDG-PET\/CT for preoperative hilar\/mediastinal staging: retrospective cohort study. Diagnostics. 2023;13:403.","journal-title":"Diagnostics"},{"key":"16580_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12880-021-00580-w","volume":"21","author":"A Al-Ibraheem","year":"2021","unstructured":"Al-Ibraheem A, Hirmas N, Fanti S, Paez D, Abuhijla F, Al-Rimawi D, et al. Impact of 18F-FDG PET\/CT, CT and EBUS\/TBNA on preoperative mediastinal nodal staging of NSCLC. BMC Med Imaging. 2021;21:49.","journal-title":"BMC Med Imaging"},{"key":"16580_CR31","doi-asserted-by":"publisher","first-page":"e78552","DOI":"10.1371\/journal.pone.0078552","volume":"8","author":"S Li","year":"2013","unstructured":"Li S, Zheng Q, Ma Y, Wang Y, Feng Y, Zhao B, et al. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of 18F-FDG PET\/CT. PLoS ONE. 2013;8:e78552.","journal-title":"PLoS ONE"},{"key":"16580_CR32","doi-asserted-by":"publisher","first-page":"eS211","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143:eS211\u2013S50.","journal-title":"Chest"},{"key":"16580_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1148\/radiol.2363041310","volume":"236","author":"SS Shim","year":"2005","unstructured":"Shim SS, Lee KS, Kim B-T, Chung MJ, Lee EJ, Han J, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET\/CT and CT alone for preoperative staging. Radiology. 2005;236:1011\u20139.","journal-title":"Radiology"},{"key":"16580_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/cncr.22518","volume":"109","author":"YK Kim","year":"2007","unstructured":"Kim YK, Lee KS, Kim B, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET\/CT in a tuberculosis\u2010endemic country. Cancer. 2007;109:1068\u201377.","journal-title":"Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:02:16Z","timestamp":1791997336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16580"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16580-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9392177\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective multicenter study was conducted in accordance with the Declaration of Helsinki. This study was approved by the Institutional Review Board of Kanagawa Cancer Center (approval numbers: 24EKI54, approved June 14, 2021; 2025EKI-121, approved November 25, 2025), the Institutional Review Board of Tokyo Medical University Hospital (SH2969), and the Institutional Review Board of Hiroshima University Hospital (E-1216). The requirement for individual written informed consent was waived by these institutional review boards owing to the study\u2019s retrospective nature.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1221"}}